Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
6.00
+0.01 (0.17%)
Jul 28, 2026, 2:38 PM EDT - Market open

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Medical Products
86.55M94.14M112.25M113.34M118.90M
Total
86.55M94.14M112.25M113.34M118.90M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
38.97M41.74M48.21M49.91M49.83M
Americas - Other
3.23M3.60M3.52M--
Europe, Middle East and Africa
26.71M28.41M33.28M--
China
10.97M13.30M18.49M16.39M13.50M
Asia - Other
6.68M7.10M8.77M--
Rest of the World
---16.34M19.81M
Europe
---30.69M35.77M
Total
86.55M94.14M112.25M113.34M118.90M